安捷伦推出首款临床光谱流式细胞仪 加码国内精准医疗赛道

Core Insights - Agilent has officially launched the NovoCyte Opteon Dx (spectral) flow cytometer in the Chinese market, marking its first clinically approved spectral flow cytometer [2] - The product features a 3-5 laser configuration and supports up to 73 detectors, utilizing full-spectrum acquisition and intelligent deconvolution technology to overcome traditional flow cytometry signal overlap limitations [3] Product Features and Applications - The NovoCyte Opteon Dx is designed to meet clinical high-throughput, high-precision, and high-compliance testing requirements, making it suitable for core clinical settings such as hospital laboratories and third-party medical labs [3] - It provides technical support for clinical needs including immunophenotyping, hematological diagnosis, and infection immune monitoring [3] Market Impact - The launch of Agilent's clinical spectral flow cytometer fills a gap in the domestic high-end spectral flow cytometry clinical equipment market, enriching the supply system of domestic high-end clinical flow cytometry products [3] - Agilent plans to continue advancing the product's technology and clinical applications, offering a one-stop solution from equipment delivery to technical support, thereby contributing to the high-quality development of precision medicine and in vitro diagnostics in China [3]